Panzyga is a prescription medication used to treat primary immunodeficiency disorders in patients who have a weakened immune system. This medication is a human immunoglobulin G (IgG) preparation that helps to boost the body’s immune response by providing antibodies that are lacking in individuals with these disorders.

Panzyga is administered intravenously by a healthcare professional and is typically given every 3 to 4 weeks, depending on the individual’s specific condition and response to treatment. It is important to follow the dosing schedule recommended by your healthcare provider to ensure the best possible outcomes.

As with any medication, Panzyga may cause side effects in some individuals. Common side effects may include headache, fatigue, fever, chills, and injection site reactions. It is important to report any unusual or severe side effects to your healthcare provider promptly.

Before starting treatment with Panzyga, it is important to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you may have. This will help to ensure that Panzyga is safe and appropriate for you.

Overall, Panzyga is a valuable treatment option for individuals with primary immunodeficiency disorders. It can help to improve immune function and reduce the risk of infections in these vulnerable patients. If you have been prescribed Panzyga, be sure to follow your healthcare provider’s instructions carefully and reach out to them with any questions or concerns you may have.